Respiratory

Latest News

Respiratory Syncytial Virus Treatment Development Discontinued

Respiratory Syncytial Virus Treatment Development Discontinued

Regeneron discontinued further development of suptavumab for respiratory syncytial virus.

Time to Sputum Culture Conversion Similar in Isoniazid-Resistant and Susceptible TB

Time to Sputum Culture Conversion Similar in Isoniazid-Resistant and Susceptible TB

A new study examined whether isoniazid resistance was associated with variations in treatment outcomes in patients receiving standard first-line pharmacotherapy for TB.

Guaifenesin/Pseudoephedrine May Reduce Antibiotic Rx for Acute URTI

Guaifenesin/Pseudoephedrine May Reduce Antibiotic Rx for Acute URTI

A 'wait-and-see' approach may reduce the number of inappropriate antibiotic prescriptions for acute upper respiratory tract infections.

Tuberculosis Detection Could Improve With Conversion Value Change

Tuberculosis Detection Could Improve With Conversion Value Change

A change of QuantiFERON-TB interferon (IFN)γ values could improve tuberculosis detection.

M tuberculosis Disrupts Regulatory Macrophage Pathways Driving Immunopathology

M tuberculosis Disrupts Regulatory Macrophage Pathways Driving Immunopathology

Mycobacterium tuberculosis engages the host immune response to drive immunopathology and tissue destruction by disrupting negative regulatory pathways in human macrophages.

Update on Safe, Effective Treatments for Latent Tuberculosis Infection

Update on Safe, Effective Treatments for Latent Tuberculosis Infection

A recent update of a meta-analysis evaluating treatments for latent tuberculosis infection found that several regimens, including those with a low pill burden and short duration, were safe and effective.

VZV-Related CAP Linked to Significant Mortality, Morbidity Rates

VZV-Related CAP Linked to Significant Mortality, Morbidity Rates

Varicella-zoster virus-related community-acquired pneumonia can be linked to significant rates of morbidity and mortality in adults.

Improving QoL in Patients With Bronchiectasis and Pseudomonas aeruginosa

Improving QoL in Patients With Bronchiectasis and Pseudomonas aeruginosa

High-doses of atorvastatin reduced inflammation and improved health-related quality of life in patients with bronchiectasis.

Mortality From ARDS Lower in High-Volume ICUs

Mortality From ARDS Lower in High-Volume ICUs

Patients admitted to high-volume intensive care units with acute respiratory distress syndrome were likely to experience a shorter hospital stay and lower mortality rate.

Mortality in MDR TB Decreases With Directly Observed Therapy

Mortality in MDR TB Decreases With Directly Observed Therapy

A decrease in all-cause mortality associated with multidrug-resistant tuberculosis (TB) can be correlated with an increase in directly observed therapy.

Sign Up for Free e-newsletters